The revised bethesda system for reporting cervical vaginal cytologic diagnoses report of the 1991 bethesda workshop bethesda maryland usa april 29 30 1991
Anon
Analytical and Quantitative Cytology and Histology 14(2): 161-163
1992
Document Number: 251980
Document emailed within 1 workday
Related Documents
1992: The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop Journal of Reproductive Medicine 37(5): 383-386Hudson, E.A.; Coleman, D.V.; Brown, C.L. 1990: The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses Acta Cytologica 34(6): 902-903
Sheridan, P.H.; Jacobs, M.P. 1996: The development of antiepileptic drugs for children. Report from the NIH workshop, Bethesda, Maryland, February 17-18, 1994 Epilepsy Research 23(1): 87-92
Weniger, B G.; Anglin, I E.; Tong, T; Pensiero, M; Pullen, J K. 2018: Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015 Vaccine 36(4): 427-437
Richard, R. Brookman 1986: National Institute for Child Health and Human Development. "Child and Adolescent Development. An Evaluation and Assessment of the State of the Science." Bethesda, MD, National Institutes of Health, 1983. (Single copies available from N.I.C.H.D., Office of Research Reporting, NIH, Building 31, Room 2A-32, Bethesda, MD 20205.) Journal of Adolescent Health Care 7(1): 68-0
Richard, R. Brookman 1986: National Institute for Child Health and Human Development. "Child and Adolescent Development. An Evaluation and Assessment of the State of the Science." Bethesda, MD, National Institutes of Health, 1983. (Single copies available from N.I.C.H.D., Office of Research Reporting, NIH, Building 31, Room 2A-32, Bethesda, MD 20205.) Journal of Adolescent Health Care 7(1): 68-0
Richard, R. Brookman 1986: National Institute for Child Health and Human Development. "Child and Adolescent Development. An Evaluation and Assessment of the State of the Science." Bethesda, MD, National Institutes of Health, 1983. (Single copies available from N.I.C.H.D., Office of Research Reporting, NIH, Building 31, Room 2A-32, Bethesda, MD 20205.) Journal of Adolescent Health Care 7(1): 68-0
Pawelec, M. 1995: Why are we afraid of cytologic descriptions using the Bethesda method? Is it a result of unfamiliarity or a result of difficulties in presentation? Report of the XIX International Workshop on Cytology in Vienna Ginekologia Polska 66(11): 651-652
Ahmed, S.; Ahmad, M.; Khan, M.Ahmad.; Kazi, F.; Noreen, F.; Nawaz, S.; Sohail, I. 2013: The interobserver reproducibility of thyroid cytopathology using Bethesda Reporting System: analysis of 200 cases Jpma. Journal of the Pakistan Medical Association 63(10): 1252-1255
Şenol, K.; Katar, Kğan.; Yüksel, C.; Saylam, Bş.; Tez, M. 2015: Prediction of Malignancy in Bethesda Category III Nodules: Application of Thyroid Imaging Reporting System American Surgeon 81(11): E351-E352
Giacomini, G.; Schnadig, V.J. 1992: The cervical Papanicolaou smear: bacterial infection and the Bethesda System Journal of the Oklahoma State Medical Association 85(6): 297
Elhakeem, H.A.; Al-Ghamdi, A.S.; Al-Maghrabi, J.A. 2005: Cytopathological pattern of cervical Pap smear according to the Bethesda system in Southwestern Saudi Arabia Saudi Medical Journal 26(4): 588-592
Virtej, P.; Vasiliu, C. 2003: Cytodiagnosis in cervical neoplasia: from the Babes/Papanicolaou smear to the actual Bethesda System Clinical and Experimental Obstetrics and Gynecology 30(4): 173-177
Richmond, B.K.; Judhan, R.; Chong, B.; Ubert, A.; AbuRahma, Z.; Mangano, W.; Thompson, S. 2014: False-negative results with the Bethesda System of reporting thyroid cytopathology: predictors of malignancy in thyroid nodules classified as benign by cytopathologic evaluation American Surgeon 80(8): 811-816
Nyklícek, O. 2005: Problems with the ASCUS (atypical squamous cells of undetermined significance) in the Bethesda system Ceska Gynekologie 70(1): 86-88
Broome, J.R. 1995: Aspects of neurological decompression illness: a view from Bethesda Journal of the Royal Naval Medical Service 81(2): 120-126
Sinn, D.H.; Chang, D.K.; Kim, Y.-H.; Rhee, P.-L.; Kim, J.J.; Kim, D.S.; Park, C.K.; Kim, J.W.; Yun, S.H.; Lee, W.-Y.; Chun, H.-K.; Rhee, J.C. 2009: Effectiveness of each Bethesda marker in defining microsatellite instability when screening for Lynch syndrome Hepato-Gastroenterology 56(91-92): 672-676
Huizinga, T.W. 1999: Gene Therapy of Arthritis and Related Disorders--First International Meeting. 2-3 December 1998, Bethesda, USA IDrugs: the investigational drugs journal 2(2): 97-99
Mulatu, K Ayele; Herold, M; Koster, H; Aguilar-Amuchastegui, N; Thompson, D; Mora, B; Wijaya, A; Skutsch, M; Calmel, M 2013: Workshop Report: Science solutions to policy challenges for evolving REDD+ measuring, reporting and verification requirements: report from a multistakeholder workshop Carbon Management 4(6): 587-590
Features Submission, H.C. 1995: National Institutes of Health Workshop Statement Nih Technology Assessment Workshop on the Persian Gulf Experience and Health April 27-29,1994 Journal of Chronic Fatigue Syndrome 1(1): 97-112